Valeant Pharmaceuticals International Inc is a specialty pharmaceutical and medical device company which develops, manufactures, and markets a range of generic and branded generic pharmaceuticals, over-the-counter products and medical devices.
Company profile
Website
CEO
Joseph C. Papa
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Icn Merger Corp, Icn Pharmaceuticals Inc
SEC CIK
Corporate docs
IRS number
330628076
Latest filings (excl ownership)
15-12B
Securities registration termination
27 Oct 10
15-12B
Securities registration termination
8 Oct 10
8-K
Valeant and Biovail Announce Results of Special Meetings of Shareholders
1 Oct 10
25-NSE
Exchange delisting
28 Sep 10
EFFECT
Notice of effectiveness
28 Sep 10
POS AM
Prospectus update (post-effective amendment)
28 Sep 10
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Sep 10
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Sep 10
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Sep 10
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Sep 10
Latest ownership filings
4
JEFFREY W UBBEN
27 May 15
SC 13G/A
Valeant Pharmaceuticals International
17 Feb 15
SC 13G/A
Beneficial ownership report (amended)
10 Feb 15
SC 13G/A
Beneficial ownership report (amended)
2 Feb 15
SC 13G/A
Valeant Pharmaceuticals International
18 Feb 14
SC 13D
BIOVAIL Corp
29 Jun 10
SC 13D/A
VA Partners I, LLC
24 Jun 10
SC 13D/A
VA Partners I, LLC
4 May 10
Institutional ownership, Q2 2022
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|